ALENDRONATE
Tracking # 20-836695
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
ALENDRONATE IS FDA-APPROVED FOR THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS, STEROID-INDUCED OSTEOPOROSIS, MALE OSTEOPOROSIS, AND PAGET DISEASE OF THE BONE. THIS ACTIVITY REVIEWS THE INDICATIONS, TARGET PATIENT, ADMINISTRATION, ADVERSE EFFECTS, MECHANISM OF ACTION, AND MONITORING OF ALENDRONATE AS PART OF AN INTERPROFESSIONAL STRATEGY.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Osteopathic Medicine
Osteopathic Physician
1h
General